BioPharm International, Partnerships for Outsourcing May 2022

Demand for outsourced services of technical R&D activities is increasing.

To build trust and ensure a high-quality product, companies must be sure their contracts are firm and their lines of communication even firmer.

CDMOs offer expertise and customization options for sponsors of orphan drugs.

CDMOs need to consistently demonstrate agility as demand increases for newly developed therapeutic modalities.

Acquisitions in the CDMO space can give us insight into a company's vision for their future.

Industry experts share their top outsourcing tips from both the perspective of companies offering outsourcing services as well as for companies looking to outsource.

The author describes how to seize market opportunities while navigating the requirements of both drug therapies and delivery devices.